Klinische Wirksamkeit und Ausblicke für die Anwendung von pegyliertem liposomalem Doxorubicin bei der Behandlung von Ovarial- und Mammakarzinomen
- 1 January 1997
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 54 (Supplement) , 22-29
- https://doi.org/10.2165/00003495-199700544-00006
Abstract
There is an urgent need for more active and better tolerated chemotherapy regimens for the treatment of advanced breast and ovarian cancers. Current therapeutic strategies in these malignancies...Keywords
This publication has 33 references indexed in Scilit:
- Treatment of advanced breast cancer with sterically stabilized liposomal doxorubicin: results of a multicenter phase II trial.Journal of Clinical Oncology, 1997
- LiposomenDrugs, 1997
- Defining response of ovarian carcinoma to initial chemotherapy according to serum CA 125.Journal of Clinical Oncology, 1996
- Response to dexamethasone in patients with fluid retention after docetaxelThe Lancet, 1996
- A New Decision Model for Cost-Utility Comparisons of Chemotherapy in Recurrent Metastatic Breast CancerPharmacoEconomics, 1996
- Key Issues in the Treatment of Advanced Breast CancerPharmacoEconomics, 1996
- High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: a randomized trial.Journal of Clinical Oncology, 1995
- High-dose chemotherapy with peripheral blood progenitor autograftingPublished by Springer Nature ,1995
- Cytoprotection: concepts and challengesSupportive Care in Cancer, 1994
- Future of cancer chemotherapy with cisplatin.1989